RAFAEL HOLDINGS, INC. Proceeds from (Repayments of) Debt
RAFAEL HOLDINGS, INC. (RFL) reported Proceeds from (Repayments of) Debt of $3.33 million for the 12-month period ending 2019-07-31, per its 10-K filed 2019-10-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2020-06-09
- RAFAEL HOLDINGS, INC. proceeds from (repayments of) debt for the quarter ending 2019-07-31 was $35.00K.
- RAFAEL HOLDINGS, INC. proceeds from (repayments of) debt for the quarter ending 2019-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. proceeds from (repayments of) debt for fiscal 2019 was $3.33M.
| Period end | Proceeds from (Repayments of) Debt 3 month | Proceeds from (Repayments of) Debt 6 month | Proceeds from (Repayments of) Debt 9 month | Proceeds from (Repayments of) Debt 12 month |
|---|---|---|---|---|
| 2019-07-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $35.00K derived: sum of 2 quarters · filed 2020-06-09 | $3.33M 10-K · filed 2019-10-04 | |
| 2019-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $3.30M 10-Q · filed 2020-06-09 | ||
| 2019-01-31 | $3.30M 10-Q · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |